{"id":"hydroxizine","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute hepatitis","Alcoholism","Angina pectoris","Angle-closure glaucoma","Benign prostatic hyperplasia","Bladder outflow obstruction","Chronic heart failure","Chronic idiopathic constipation","Chronic myocardial ischemia","Conduction disorder of the heart","Continuous fever","Cor pulmonale","Cystic fibrosis","Diabetes mellitus","Disease of liver","Disorder of cardiovascular system","Disorder of coronary artery","Hypertensive disorder","Hyperthyroidism","Hypothyroidism","Multiple organ failure","Myocardial infarction","Myocardial ischemia","Open-angle glaucoma","Peptic ulcer","Psychotic disorder","Pulmonary edema","Retention of urine","Seizure disorder","Sepsis syndrome","Severe Hypoxemia","Shock","Smokes tobacco daily","Smoking cessation assistance","Tachyarrhythmia","Theophylline Toxicity","Third trimester pregnancy"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"5-hydroxytryptamine receptor 2A, Cytochrome P450 2D6, D(2) dopamine receptor"},"_scrapedAt":"2026-03-28T05:43:43.290Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Allergic conjunctivitis","diseaseId":"allergic-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Atopic dermatitis","diseaseId":"atopic-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dermatographic urticaria","diseaseId":"dermatographic-urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Itching of skin","diseaseId":"itching-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nasal discharge","diseaseId":"nasal-discharge","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urticaria","diseaseId":"urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07472413","phase":"PHASE3","title":"Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-07-01","conditions":"Multiple Sclerosis","enrollment":60},{"nctId":"NCT02858310","phase":"PHASE1, PHASE2","title":"E7 TCR T Cells for Human Papillomavirus-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-27","conditions":"Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ","enrollment":224},{"nctId":"NCT04580134","phase":"PHASE4","title":"CLOZAPINE Response in Biotype-1","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-03-01","conditions":"Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder","enrollment":524},{"nctId":"NCT02604199","phase":"PHASE2","title":"A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-09","conditions":"Hepatitis B","enrollment":58},{"nctId":"NCT02738008","phase":"PHASE2","title":"Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) Infection","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2016-03","conditions":"Hepatitis B","enrollment":12},{"nctId":"NCT02577029","phase":"PHASE2","title":"Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-12","conditions":"Hepatitis B, Hepatitis D","enrollment":79},{"nctId":"NCT02604212","phase":"PHASE2","title":"A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Positive, Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-11","conditions":"Hepatitis B","enrollment":32},{"nctId":"NCT02535416","phase":"PHASE1","title":"A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2015-09","conditions":"Healthy","enrollment":40},{"nctId":"NCT02797522","phase":"PHASE1","title":"A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2016-06","conditions":"Hepatitis B","enrollment":47},{"nctId":"NCT03808805","phase":"PHASE3","title":"Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2019-04-16","conditions":"Myeloproliferative Disorder, Aquagenic Pruritus","enrollment":63},{"nctId":"NCT07236372","phase":"NA","title":"Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria","status":"NOT_YET_RECRUITING","sponsor":"University of Phayao","startDate":"2025-11","conditions":"Acute Urticaria","enrollment":140},{"nctId":"NCT06019728","phase":"PHASE4","title":"A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme","status":"COMPLETED","sponsor":"Sanofi","startDate":"2023-11-10","conditions":"Fabry's Disease","enrollment":8},{"nctId":"NCT04347603","phase":"NA","title":"Sedation or General Anesthesia During TAVR","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2020-12-08","conditions":"Stenoses, Aortic","enrollment":218},{"nctId":"NCT05946551","phase":"PHASE3","title":"Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial","status":"TERMINATED","sponsor":"Emory University","startDate":"2024-03-08","conditions":"COVID-19","enrollment":5},{"nctId":"NCT04814381","phase":"PHASE4","title":"Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2021-09-15","conditions":"Refractory Chronic Cluster Headache","enrollment":90},{"nctId":"NCT06080100","phase":"EARLY_PHASE1","title":"RELIEF OF PSYCHOEMOTIONAL STRESS USING XENON SEDATION","status":"RECRUITING","sponsor":"The S.N. Fyodorov Eye Microsurgery State Institution","startDate":"2023-11-01","conditions":"Psychological Stress, Anesthesia, Anxiety","enrollment":140},{"nctId":"NCT07031206","phase":"PHASE2","title":"Investigating Pre-Procedural Anxiety and Effect of Analgesia on Intrauterine Device Placement and Endometrial Biopsy","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-01","conditions":"Anxiety, Pain","enrollment":152},{"nctId":"NCT06890260","phase":"NA","title":"The Treatment of Moderate to Severe Allergic Rhinitis With Electroacupuncture Combined With Microneedle Knife","status":"RECRUITING","sponsor":"Pengfei Qiu","startDate":"2025-04-11","conditions":"Allergic Rhinitis (Disorder), Electroacupuncture, Microneedle Knife","enrollment":90},{"nctId":"NCT06819774","phase":"PHASE3","title":"Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria","status":"RECRUITING","sponsor":"Shandong New Time Pharmaceutical Co., LTD","startDate":"2024-04-22","conditions":"Acute Urticaria","enrollment":284},{"nctId":"NCT05042479","phase":"NA","title":"Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2022-06-30","conditions":"Hematologic Malignancy, Hematologic Non Malignancy, Solid Tumor, Childhood","enrollment":34},{"nctId":"NCT06754410","phase":"PHASE3","title":"Efficacy of Antihistamine Drugs as Medical Expulsive Therapy Alone or in Combination With Alpha Blockers: A Prospective Randomized Controlled Study","status":"COMPLETED","sponsor":"South Valley University","startDate":"2021-03-01","conditions":"Lower Ureteric Stones","enrollment":480},{"nctId":"NCT03167216","phase":"EARLY_PHASE1","title":"Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-08-01","conditions":"Chronic Prostatitis With Chronic Pelvic Pain Syndrome","enrollment":20},{"nctId":"NCT05126459","phase":"PHASE3","title":"A Comparison of Oral Sedation-related Events of Three Multiagent Oral Sedation Regimens in Pediatric Dental Patients","status":"COMPLETED","sponsor":"Loma Linda University","startDate":"2022-02-14","conditions":"Anxiety, Dental, Dental Decay","enrollment":60},{"nctId":"NCT06039137","phase":"","title":"The Effect of Switching the H1-antagonist Clemastine to Cetirizine in Premedication Regimens During Paclitaxel Treatment","status":"COMPLETED","sponsor":"Erasmus Medical Center","startDate":"2022-06-01","conditions":"Solid Tumor","enrollment":395},{"nctId":"NCT04609956","phase":"NA","title":"Virtual Reality Technology on Pain Perception and Anxiety Levels in Adolescents and Young Adults During Third Molar Germ Avulsion Surgery (VIDAMO)","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2021-02-16","conditions":"Anxiety, Dental","enrollment":100},{"nctId":"NCT00751218","phase":"PHASE4","title":"A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-05-06","conditions":"Urticaria","enrollment":174},{"nctId":"NCT00751166","phase":"PHASE4","title":"A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2004-03-01","conditions":"Urticaria","enrollment":149},{"nctId":"NCT06535087","phase":"","title":"The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life","status":"RECRUITING","sponsor":"Wenjing Zhou","startDate":"2024-07-20","conditions":"Pediatric Asthma, Rhinitis, Allergic, Quality of Life","enrollment":600},{"nctId":"NCT04071821","phase":"PHASE1","title":"Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg","status":"NOT_YET_RECRUITING","sponsor":"Seattle Gummy Company","startDate":"2025-05-01","conditions":"Allergy","enrollment":30},{"nctId":"NCT00650065","phase":"PHASE1","title":"Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-11","conditions":"Healthy","enrollment":26},{"nctId":"NCT00649857","phase":"PHASE1","title":"Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2002-11","conditions":"Healthy","enrollment":18},{"nctId":"NCT04990388","phase":"PHASE1, PHASE2","title":"Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)","status":"TERMINATED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-10-18","conditions":"Glycogen Storage Disease Type III","enrollment":9},{"nctId":"NCT05095311","phase":"PHASE4","title":"The Effect of Cetirizine HCl on Exercise-induced Arterial Hypoxemia in Highly-trained Swimmers","status":"TERMINATED","sponsor":"Indiana University","startDate":"2021-05-19","conditions":"Exercise-induced Arterial Hypoxemia","enrollment":16},{"nctId":"NCT02023164","phase":"PHASE3","title":"Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria","status":"COMPLETED","sponsor":"JDP Therapeutics, Inc.","startDate":"2013-07","conditions":"Acute Urticaria","enrollment":36},{"nctId":"NCT06126991","phase":"PHASE1, PHASE2","title":"Organ Protective Effect of Cetirizine In Patients With Severe Burns","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2024-01-23","conditions":"Burns","enrollment":32},{"nctId":"NCT04068948","phase":"PHASE4","title":"Comparing Pediatric Dental Oral Sedation Outcomes With and Without Meperidine in Children Aged 3-7 Years","status":"COMPLETED","sponsor":"University of Washington","startDate":"2019-06-25","conditions":"Dental Caries in Children, Pediatric Dental Sedation, Meperidine","enrollment":37},{"nctId":"NCT05680584","phase":"PHASE1","title":"Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy","status":"UNKNOWN","sponsor":"Minia University","startDate":"2023-02-01","conditions":"Effect of Drug, Anxiety","enrollment":78},{"nctId":"NCT04189588","phase":"PHASE2","title":"Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine","status":"COMPLETED","sponsor":"TerSera Therapeutics LLC","startDate":"2020-03-25","conditions":"Oncology Patients Receiving Chemotherapy","enrollment":34},{"nctId":"NCT03453632","phase":"PHASE2, PHASE3","title":"Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex","status":"UNKNOWN","sponsor":"University Hospital, Toulouse","startDate":"2018-06-14","conditions":"Epidermolysis Bullosa Simplex","enrollment":25},{"nctId":"NCT02865018","phase":"PHASE1, PHASE2","title":"Neuromyelitis Optica (NMO) & Cetirizine","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-04","conditions":"Neuromyelitis Optica","enrollment":16},{"nctId":"NCT04280965","phase":"EARLY_PHASE1","title":"Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2019-02-01","conditions":"Post Traumatic Stress Disorder","enrollment":28},{"nctId":"NCT04188106","phase":"PHASE4","title":"Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2019-06-17","conditions":"Smoking Cessation, Stress, Sleep Disturbance","enrollment":26},{"nctId":"NCT05737511","phase":"PHASE4","title":"Efficacy of Hydroxyzine for Patients With Panic Disorder","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2023-12-30","conditions":"Panic Disorder","enrollment":80},{"nctId":"NCT04481412","phase":"PHASE2, PHASE3","title":"Topical Cetirizine in Androgenetic Alopecia in Females","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-07-25","conditions":"Androgenetic Alopecia","enrollment":66},{"nctId":"NCT03158376","phase":"PHASE3","title":"Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE).","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2015-09","conditions":"Postoperative Pain, Chronic Pain","enrollment":201},{"nctId":"NCT03340740","phase":"PHASE4","title":"The Effect of Cetirizine on Bronchoconstriction","status":"COMPLETED","sponsor":"New York City Health and Hospitals Corporation","startDate":"2018-05-11","conditions":"Allergic Rhinitis, Asthma","enrollment":40},{"nctId":"NCT05492812","phase":"NA","title":"Sedation and Nursing Management in EEG Recording in Children","status":"COMPLETED","sponsor":"Suleyman Demirel University","startDate":"2021-01-01","conditions":"Electroencephalography, Melatonin, Chloral Hydrate","enrollment":180},{"nctId":"NCT00794846","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03180)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":124},{"nctId":"NCT00794599","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":118},{"nctId":"NCT00794495","phase":"PHASE4","title":"Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis","enrollment":122},{"nctId":"NCT00794794","phase":"PHASE3","title":"Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03826)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Allergic Rhinitis","enrollment":204},{"nctId":"NCT00794378","phase":"PHASE3","title":"Taste Test Between Desloratadine and Cetirizine Syrup in Children (Study P03829)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11","conditions":"Allergic Rhinitis","enrollment":202},{"nctId":"NCT00780403","phase":"PHASE4","title":"Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-08","conditions":"Allergies","enrollment":220},{"nctId":"NCT00779116","phase":"PHASE4","title":"Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Allergies","enrollment":217},{"nctId":"NCT05224167","phase":"NA","title":"Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture","status":"UNKNOWN","sponsor":"Mongi Slim Hospital","startDate":"2022-03-01","conditions":"Preoperative Anxiety","enrollment":50},{"nctId":"NCT03772158","phase":"PHASE1","title":"Cetirizine Chewable Bioequivalence and Food Effect Study","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division","startDate":"2018-12-11","conditions":"Allergy","enrollment":40},{"nctId":"NCT04179461","phase":"PHASE2","title":"Personalized Treatment Algorithms for Difficult-to-treat Asthma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-03-16","conditions":"Asthma in Children","enrollment":21},{"nctId":"NCT04836806","phase":"PHASE4","title":"Cetirizine and Famotidine for COVID-19","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2021-08","conditions":"Covid19","enrollment":""},{"nctId":"NCT01971853","phase":"NA","title":"Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2013-10","conditions":"Pain","enrollment":88},{"nctId":"NCT04237090","phase":"PHASE3","title":"Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2020-02-14","conditions":"Breast Cancer, Lung Cancer, Ovarian Cancer","enrollment":27},{"nctId":"NCT03324828","phase":"PHASE4","title":"Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)","status":"TERMINATED","sponsor":"Hospital San Carlos, Madrid","startDate":"2017-11-01","conditions":"Anxiety","enrollment":170},{"nctId":"NCT03192488","phase":"PHASE4","title":"Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia","status":"COMPLETED","sponsor":"Indiana University","startDate":"2017-08-31","conditions":"Hypoxia, Altitude","enrollment":13},{"nctId":"NCT04293822","phase":"PHASE4","title":"Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-06","conditions":"Androgenetic Alopecia","enrollment":60},{"nctId":"NCT04184141","phase":"PHASE4","title":"Preoperative Use of Alprazolam and Hydroxyzine in Anxiety","status":"UNKNOWN","sponsor":"Istanbul Medeniyet University","startDate":"2019-12-01","conditions":"Agitation on Recovery From Sedation","enrollment":90},{"nctId":"NCT03806270","phase":"","title":"Hydroxyzine Dihydrochloride Premedication is a Necessity for Strabismus Surgery","status":"COMPLETED","sponsor":"Yeditepe University","startDate":"2018-10-01","conditions":"Strabismus, Reflex, Oculocardiac, Hydroxyzine","enrollment":45},{"nctId":"NCT03047278","phase":"PHASE4","title":"Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.","status":"COMPLETED","sponsor":"Natalia Valadares de Moraes","startDate":"2015-11-01","conditions":"Neuropathic Pain, Type 2 Diabetes Mellitus, Diabetic Neuropathy, Painful","enrollment":29},{"nctId":"NCT01241214","phase":"PHASE2","title":"Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2010-11","conditions":"Seasonal Allergic Rhinitis","enrollment":579},{"nctId":"NCT02543346","phase":"PHASE4","title":"Comparability and Standardization of Controlled Allergen Challenge Facilities","status":"COMPLETED","sponsor":"Queen's University","startDate":"2015-10","conditions":"Allergic Rhinitis","enrollment":98},{"nctId":"NCT03728894","phase":"PHASE3","title":"Oral Sedation With and Without Nitrous Oxide","status":"COMPLETED","sponsor":"Tishreen University","startDate":"2018-11-17","conditions":"Behavior, Child","enrollment":30},{"nctId":"NCT01825655","phase":"PHASE4","title":"Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching","status":"TERMINATED","sponsor":"Virginia Commonwealth University","startDate":"2014-09","conditions":"Pruritus","enrollment":3},{"nctId":"NCT01484119","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2011-12","conditions":"Seasonal Allergic Rhinitis","enrollment":630},{"nctId":"NCT00291642","phase":"PHASE2","title":"A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed Pollen","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-01-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":551},{"nctId":"NCT01916226","phase":"PHASE4","title":"A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08-01","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":682},{"nctId":"NCT02374567","phase":"PHASE3","title":"Pharmacovigilance in Gerontopsychiatric Patients","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2015-01","conditions":"Dementia, Depression, Schizophrenia","enrollment":407},{"nctId":"NCT01495338","phase":"PHASE1","title":"A Comparison of the Safety and Comfort of AC-170","status":"COMPLETED","sponsor":"Aciex Therapeutics, Inc.","startDate":"2011-12","conditions":"Normal Ocular Health","enrollment":60},{"nctId":"NCT02756624","phase":"PHASE3","title":"A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution","status":"COMPLETED","sponsor":"Nicox Ophthalmics, Inc.","startDate":"2016-04","conditions":"Healthy Subjects","enrollment":516},{"nctId":"NCT00490204","phase":"PHASE3","title":"Cetirizine Placebo Controlled Study For Perennial Allergic Rhinitis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-07-27","conditions":"Rhinitis, Allergic, Perennial","enrollment":239},{"nctId":"NCT02447393","phase":"PHASE1","title":"Phase 1 Study of Levocetirizine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-18","conditions":"Dermatitis","enrollment":20},{"nctId":"NCT00972504","phase":"PHASE2","title":"723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-06-01","conditions":"Rhinitis, Allergic, Seasonal","enrollment":54},{"nctId":"NCT02613910","phase":"PHASE3","title":"Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2015-12-23","conditions":"Pemphigus","enrollment":1},{"nctId":"NCT01622283","phase":"PHASE1","title":"Pharmacokinetic Study of Levocetirizine Oral Solution","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-05-02","conditions":"Rhinitis, Allergic, Perennial and Seasonal","enrollment":20},{"nctId":"NCT00661674","phase":"NA","title":"Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal","status":"COMPLETED","sponsor":"Stanford University","startDate":"2008-04","conditions":"Substance-Related Disorders","enrollment":10},{"nctId":"NCT02932774","phase":"PHASE4","title":"Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer and Personal Products Worldwide","startDate":"2001-03","conditions":"Allergic Rhinitis, Hay Fever, SAR","enrollment":683},{"nctId":"NCT01501591","phase":"NA","title":"Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size","status":"COMPLETED","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2012-11","conditions":"Placebo Effect, Placebo Drug Interaction","enrollment":480},{"nctId":"NCT01557712","phase":"PHASE3","title":"Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2012-03","conditions":"Major Depressive Disorder","enrollment":25},{"nctId":"NCT01103050","phase":"PHASE2","title":"A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-03-22","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT01372670","phase":"PHASE4","title":"Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder","status":"WITHDRAWN","sponsor":"HealthPartners Institute","startDate":"2012-01","conditions":"Anxiety in Those Patients With Anorexia Nervosa, Eating Disorder Not Otherwise Specified, BMI (<=18)","enrollment":""},{"nctId":"NCT00851344","phase":"PHASE2","title":"Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-09","conditions":"Rhinitis, Allergic, Seasonal","enrollment":54},{"nctId":"NCT01675986","phase":"PHASE2","title":"Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score","status":"COMPLETED","sponsor":"Poitiers University Hospital","startDate":"","conditions":"Feeling Anxious","enrollment":306},{"nctId":"NCT02814981","phase":"","title":"Hydroxyzine and Risk of Prolongation of QT Interval","status":"UNKNOWN","sponsor":"University Hospital, Caen","startDate":"2015-11","conditions":"Hydroxyzine, Long QT Syndrome","enrollment":130},{"nctId":"NCT02205489","phase":"PHASE4","title":"Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2014-10","conditions":"Relapsing-remitting Multiple Sclerosis","enrollment":58},{"nctId":"NCT00332163","phase":"PHASE2","title":"Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-04","conditions":"Metastatic Colorectal Cancer, Skin Rash, Skin Toxicities","enrollment":95},{"nctId":"NCT00260481","phase":"PHASE2, PHASE3","title":"Prometa Pharmacotherapy for Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2006-01","conditions":"Drug Abuse, Drug Dependence","enrollment":120},{"nctId":"NCT01985789","phase":"PHASE4","title":"Anti-histamines and Methacholine Challenges.","status":"COMPLETED","sponsor":"Don Cockcroft","startDate":"2013-11","conditions":"Asthma","enrollment":12},{"nctId":"NCT01151696","phase":"PHASE4","title":"Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2010-05","conditions":"Pain","enrollment":140},{"nctId":"NCT01981499","phase":"PHASE1","title":"A Study of the Safety, Tolerability, Pharmacokinetics, And Effects On Histamine-Induced Wheal Of PF-05180999 In Healthy Adults","status":"TERMINATED","sponsor":"Pfizer","startDate":"2014-01","conditions":"Migraine","enrollment":31},{"nctId":"NCT01748344","phase":"PHASE2","title":"Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Ono Pharmaceutical Co. Ltd","startDate":"2012-11","conditions":"Seasonal Allergic Rhinitis","enrollment":58},{"nctId":"NCT00826943","phase":"PHASE4","title":"Is Levocetirizine Less Sedating Than Cetirizine?","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2009-01","conditions":"Allergic Rhinitis","enrollment":30},{"nctId":"NCT01940393","phase":"PHASE4","title":"Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria","status":"COMPLETED","sponsor":"Grupo de Alergología Clínica y Experimental","startDate":"2013-08","conditions":"Urticaria","enrollment":150},{"nctId":"NCT01318681","phase":"NA","title":"Rhinitis, Cognition and Driving Performance","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2011-01","conditions":"Seasonal Allergic Rhinitis, Driving Ability, Cognition","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Immunology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_1","status":"active","brandName":"Hydroxizine","genericName":"Hydroxizine","companyName":"King Faisal Specialist Hospital & Research Center","companyId":"king-faisal-specialist-hospital-research-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}